Efficient Trial Design - FDA Approval of Valbenazine for Tardive Dyskinesia
NEJM 376:2503-2506, Davis, M.C.,et al, 2017
Withdrawing Amantadine in Dyskinetic Patients with Parkinson Disease
Neurol 82:300-307, Ory-Magne, F.,et al, 2014
Evidence-Based Guideline: Treatment of Tardive Syndromes
Neurol 81:463-469, Bhidayasiri, R.,et al, 2013
Tardive Dyskinesia:Diagnosis, Pathogenesis, and Management
The Neurologist 4:180-187, Trugman,J.M., 1998
Dystonia and Chorea in Acquired Systemic Disorders
JNNP 65:436-445, Janavs,J.L.&Aminoff,M.J., 1998
Oral and Genital Tardive Pain Syndromes
Neurol 44:2115-2119, Ford,B.,et al, 1994
Tardive Stereotype and Other Movement Disorders in Tardive Dyskinesias
Neurol 43:937-941, Stacy,M.,et al, 1993
Aggravation of Tardive Dyskinesia by Phenytoin
NEJM 298:457, DeVeaugh-Geiss,J., 1978
Oral Facial Dyskinesia Assoc. with Prolonged use of Antihistamine Decongestants
NEJM 293:486, Thach,B.T.,et al, 1975
Clinical Diagnosis of the Dyskinesias
Med Clin of North Am 56:1321, Duvoisin,R., 1972